<DOC>
	<DOCNO>NCT00387257</DOCNO>
	<brief_summary>The purpose study compare effect repeat dose SB-659032 placebo platelet aggregation subject .</brief_summary>
	<brief_title>Effect Of Rilapladib ( SB-659032 ) On Platelet Aggregation</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Subjects QTc &lt; 450 msec measure screen . History asthma . Smokers .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>platelet aggregation</keyword>
	<keyword>SB-659032</keyword>
	<keyword>rilapladib</keyword>
</DOC>